Congressional Republicans are seeking answers from the US Food and Drug Administration’s (FDA) about its internal scientific dispute resolution process. The investigation follows a recent Government Accountability Office (GAO) report that raised concerns about political interference during the COVID-19 pandemic.
In a letter to FDA Commissioner Robert Califf dated 3 January, House Energy and Commerce (E&C) Committee Chair Cathy McMorris Rodgers (R-WA), E&C Health Subcommittee Chair Brett Guthrie (R-KY) and Subcommittee on Oversight and Investigations Chair H. Morgan Griffith (R-VA) wrote that they are concerned about potential political pressure from the Biden Administration that may have compromised the agency’s ability to make independent decisions…
